Jeffrey Lipton

27PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyBiological physicsFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 24, 2026
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

|Apr 16, 2026
The Role of Allogeneic Hematopoietic Cell Transplantation in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.

|Apr 13, 2026
Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision-Making.

Arjun Datt Law, Jeffrey H Lipton

|May 20, 2025
Watching the Barn Door Open-Timing CML Stem Cell Allografts.

Jeffrey H Lipton

|May 14, 2025
Has the time for treatment-free remission in Philadelphia chromosome-positive acute lymphoblastic leukemia arrived?

Ehab Atallah, Jeffrey H Lipton

|May 06, 2025
Allorgafting for Aplastic Anemia on a Background of HELLP Syndrome in Identical Twins.

Jeffrey H Lipton

Pageof 5

Frequent Collaborators

17 joint publications

Fotios V Michelis

13 joint publications

Ivan Pasic

11 joint publications

Dennis Kim

6 joint publications

Igor Novitzky-Basso